Who is sponsoring NCT04272541?

NCT04272541 is sponsored by Universidad de Granada.

What drugs are being tested in NCT04272541?

Interventions in NCT04272541: Psychoeducation program, Psychopharmacology intervention.

What condition does NCT04272541 study?

NCT04272541 studies Mental Health Disorder, Healthy Lifestyle.

Is NCT04272541 still recruiting?

NCT04272541 is currently completed. Last updated 7 July 2021.

Last reviewed 2021-07-07 · How we verify

NCT04272541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Psychoeducation Program in Patients With Severe Mental Disorder

Completed NA Last updated 7 July 2021

What this trial tests

NA trial testing Psychoeducation program in Mental Health Disorder in 60 participants. Completed in 20 November 2020.

Timeline

20 February 2020

Primary endpoint
20 November 2020

20 November 2020

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	20 February 2020
Primary completion	20 November 2020
Estimated completion	20 November 2020
Sites	1 location across Spain

Drugs / interventions tested

Psychoeducation program
Psychopharmacology intervention — full drug profile →

Conditions studied

Mental Health Disorder — all drugs for Mental Health Disorder →
Healthy Lifestyle — all drugs for Healthy Lifestyle →

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 40 to 90, any sex, with Mental Health Disorder or Healthy Lifestyle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with Severe Mental Disorder (SMD) show a life expectancy of 13 to 30 years lower than the general population. Among the factors that determine this expectancy are cardiovascular risk and the metabolic syndrome. The objective of the present study will be to evaluate the effectiveness of a rehabilitative intervention comprinsing a psychopharmacology and psychoeducation program on cardiovascular risk, metabolic syndrome, independency for activities of daily living and psychopathological symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for the management of obesity in people with bipolar disorder.
Tully A, Smyth S, Conway Y, Geddes J, et al · · 2020 · cited 18× · PMID 32687629 · DOI 10.1002/14651858.cd013006.pub2

Verify or expand the search:

Other trials of Psychoeducation program

Trials testing the same drug.

NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
NCT06981910 — The Role of Psychoeducation in Breast Cancer Care · NA · completed

Other recruiting trials for Mental Health Disorder

Currently open trials in the same condition.

NCT07150832 — Efficacy of the I-CARE Digital Health Intervention · NA · recruiting
NCT06665620 — Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents · NA · active not recruiting
NCT07054554 — Engaging Mental Health Services for Preschoolers at Risk · NA · recruiting
NCT06980233 — Reentry Assist (R-Assist) · NA · active not recruiting
NCT05920252 — A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide · NA · recruiting

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04272541 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 7 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04272541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing